ESC Professional Premium Access

Comparison of clinical and economic burden of pulmonary arterial hypertension patients with and without connective tissue disease treated with macitentan

Congress Session

About the speaker

Doctor Carly Worden

Janssen Pharmaceuticals, Titusville (United States of America)
0 follower

4 more presentations in this session

Persistence with macitentan versus other endothelin receptor antagonists in patients with pulmonary arterial hypertension: experience from a real-world data repository in the USA

Speaker: Doctor S. Panjabi (San Mateo, US)

Thumbnail

Additional opportunities for antihypertensive therapy improvement in young patients with arterial hypertension and concomitant obesity

Speaker: Doctor K. Chernyshova (Odessa, UA)

Thumbnail

The music therapy effectiveness in hypertensive patients with acute myocardial infarction after previous coronary artery bypass surgery; 18-year experience of the MUSIC study

Speaker: Professor P. Mitrovic (Belgrade, RS)

Thumbnail

Angiotensin receptor blockers are equally effective in women and men; a systematic review and meta-analysis

Speaker: Mrs S. Laven (Maastricht, NL)

Thumbnail

Access the full session

Hypertension - Treatment lifestyle and pharmacotherapy

Speakers: Doctor C. Worden, Doctor S. Panjabi, Doctor K. Chernyshova, Professor P. Mitrovic, Mrs S. Laven
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk